(Q45250378)

11 December 2017

title

Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function (English)

1 reference

11 December 2017

0 references

2

Bart Barlogie

1 reference

11 December 2017

8

Paul G Richardson

1 reference

11 December 2017

12

Kenneth C Anderson

1 reference

11 December 2017

7

Robert Z Orlowski

1 reference

11 December 2017

3

James R Berenson

1 reference

11 December 2017

4

Seema Singhal

1 reference

11 December 2017

1

Sundar Jagannath

1 reference

11 December 2017

6

Gordan Srkalovic

1 reference

11 December 2017

5

Raymond Alexanian

1 reference

SUMMIT/CREST Investigators

11 December 2017

series ordinal

13

object named as

SUMMIT/CREST Investigators

1 reference

11 December 2017

11

Dixie L Esseltine

1 reference

11 December 2017

Jessica Anderson

9

1 reference

11 December 2017

Darrell Nix

series ordinal

10

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

11 December 2017

1 reference

11 December 2017

volume

103

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

1195-1200

1 reference

Renal Failure in Multiple Myeloma

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Renal involvement in multiple myeloma: a 10-year study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Gene therapy for inherited disorders of haematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Review of 1027 patients with newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Renal impairment in myeloma: time for a reappraisal?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20888

7 January 2021

Identifiers

DOI

10.1002/CNCR.20888

1 reference

release_qgmgfhxjtrh75ae5zhuf7ujece

11 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qgmgfhxjtrh75ae5zhuf7ujece

24 November 2022

mapped directly with Wikidata item

1 reference